PIK3CA and head and neck squamous cell carcinoma: PI3K/Akt/mTOR pathway is the most frequently mutated pathway (11–30%) in HNSCC patients [132,133], in contrast to JAK/STAT or the MAPK pathways (8–12%) [133] (Figure 1).